Post Profile

Thousands of melanoma patients in Europe have no access to new life saving drugs

(European Society for Medical Oncology) Over 5,000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.
read more


Related Posts

Thousands of European melanoma patients lack access to new drugs

Health : Reuters: Health

COPENHAGEN (Reuters) - More than a quarter of European patients with advanced melanoma lack access to new treatments that could extend their lives, according to findings presented at a major cancer conference on Friday.

Merck KGaA: Erbitux - First Treatment In 30 Years To Prolong Survival In 1st-Line Recurrent And/Or Metastatic Head And Neck Cancer

Health : Medical News Today

Data presented at the 33rd European Society for Medical Oncology (ESMO) Congress in Stockholm demonstrate that the addition of Erbitux® (cetuximab) to platinum-based chemotherapy increases overall survival (OS) compared to chemother...

Biothera To Present Research Results At European Society For Medical Oncology World Gastrointestinal Congress

Health : Medical News Today

Biothera has been accepted to present data from its Phase II clinical trial in stage IV KRAS-mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25 in B...

The First Ever Estimate Of The Economic Burden Of Cancer In Europe Shows That It Exceeds 124 Billion Euros

Health : Medical News Today

New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe will be presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. "Here we ha...

Drug Trials Seek Combinations Effective For Melanoma

Health : Medical News Today

Promising new data from trials aimed at delaying resistance to BRAF inhibitors Promising new data on drug combinations to treat metastatic melanoma were presented at the ESMO 2012 Congress of the European Society for Medical Oncolog...


Copyright © 2016 Regator, LLC